References
- Nakhla PS, Butera JN, Treaba DO, et al. Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype. Leuk Lymphoma 2013;54:1647–1651.
- Everson TC. Spontaneous regression of cancer. Prog Clin Cancer 1967;3:79–95.
- Papac RJ. Spontaneous regression of cancer. Cancer Treat Rev 1996;22:395–423.
- Jessy T. Immunity over inability:the spontaneous regression of cancer. J Nat Sci Biol Med 2011;2:43–49.
- Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression: a place in history or in the future?Postgraduate Med J 2003;79:672–680.
- Musto P, D’Arena G, Melillo L, et al. Spontaneous remission in acute myeloid leukaemia: a role for endogenous production of tumour necrosis factor and interleukin-2?Br J Haematol 1994;87:879–880.
- Del Giudice I, Chiaretti S, Tavolaro S, et al. Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases. Blood 2009;114:638–646.
- Berrebi A, Shtalrid M, Klepfish A, et al. Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia. Leukemia 1994;8:2214–2216.
- D’Arena G, Laurenti L, Coscia M, et al. Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey. Leuk Lymphoma 2014;55:841–847.
- Shanafelt TD, Call TG, Zent CS, et al. Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer 2013;119:363–370.
- D’Arena G, Simeon V, De Martino L, et al. Regulatory T-cell modulation by green tea in chronic lymphocytic leukemia. Int J Immunopathol Pharmacol 2013;26:117–125.
- D’Arena G, Rossi G, Minervini MM, et al. Circulating regulatory T cells in “clinical” monoclonal B-cell lymphocytosis. Int J Immunopathol Pharmacol 2011;24:915–923.
- D’Arena G, Gemei M, Luciano L, et al. Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?J Clin Oncol 2012;30:e327–e330.
- Peveling-Oberhag J, Arcaini L, Hansmann ML, et al. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 2013;59:169–177.
- Arcaini L, Merli M, Volpetti S, et al. Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy. Clin Dev Immunol 2012;2012:638185.
- Marcucci F, Mele A, Spada E, et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica 2006;91:554–557.